DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 190 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $105,257,083 | -9.8% | 9,372,848 | -0.3% | 0.00% | 0.0% |
Q1 2024 | $116,681,873 | -10.0% | 9,402,246 | +1.4% | 0.00% | -33.3% |
Q4 2023 | $129,675,515 | -4.0% | 9,275,788 | +1.4% | 0.00% | 0.0% |
Q3 2023 | $135,099,580 | +17.8% | 9,146,891 | +3.1% | 0.00% | 0.0% |
Q2 2023 | $114,680,000 | +38.3% | 8,876,161 | +5.0% | 0.00% | +50.0% |
Q1 2023 | $82,903,310 | -6.6% | 8,450,898 | +1.3% | 0.00% | 0.0% |
Q4 2022 | $88,789,331 | +4.2% | 8,344,862 | +2.2% | 0.00% | -33.3% |
Q3 2022 | $85,249,000 | -15.6% | 8,165,641 | +1.8% | 0.00% | 0.0% |
Q2 2022 | $101,023,000 | +59.5% | 8,023,967 | +37.3% | 0.00% | +200.0% |
Q1 2022 | $63,339,000 | -23.8% | 5,843,198 | -1.0% | 0.00% | -50.0% |
Q4 2021 | $83,074,000 | -23.1% | 5,904,309 | +5.0% | 0.00% | -33.3% |
Q3 2021 | $107,971,000 | +89.5% | 5,620,510 | -2.8% | 0.00% | +200.0% |
Q2 2021 | $56,986,000 | +8.9% | 5,785,376 | +8.7% | 0.00% | 0.0% |
Q1 2021 | $52,313,000 | +130.0% | 5,321,843 | +4.1% | 0.00% | 0.0% |
Q4 2020 | $22,748,000 | +1.1% | 5,111,996 | -1.8% | 0.00% | 0.0% |
Q3 2020 | $22,496,000 | -49.2% | 5,207,678 | +4.4% | 0.00% | -50.0% |
Q2 2020 | $44,247,000 | +182.5% | 4,988,427 | +12.4% | 0.00% | +100.0% |
Q1 2020 | $15,661,000 | -34.0% | 4,436,367 | +7.0% | 0.00% | 0.0% |
Q4 2019 | $23,723,000 | +52.5% | 4,147,494 | -4.7% | 0.00% | 0.0% |
Q3 2019 | $15,560,000 | +8.2% | 4,352,722 | +20.8% | 0.00% | 0.0% |
Q2 2019 | $14,377,000 | -37.1% | 3,603,383 | +15.2% | 0.00% | 0.0% |
Q1 2019 | $22,869,000 | -12.5% | 3,128,380 | +9.5% | 0.00% | 0.0% |
Q4 2018 | $26,141,000 | -26.9% | 2,856,869 | -0.9% | 0.00% | 0.0% |
Q3 2018 | $35,759,000 | -17.8% | 2,883,887 | +1.0% | 0.00% | -50.0% |
Q2 2018 | $43,522,000 | -17.3% | 2,853,989 | +7.6% | 0.00% | 0.0% |
Q1 2018 | $52,641,000 | +5.2% | 2,651,928 | -0.9% | 0.00% | 0.0% |
Q4 2017 | $50,034,000 | -10.7% | 2,675,607 | +2.7% | 0.00% | -33.3% |
Q3 2017 | $56,011,000 | +186.7% | 2,605,171 | +28.7% | 0.00% | +200.0% |
Q2 2017 | $19,538,000 | +79.8% | 2,024,666 | +10.9% | 0.00% | 0.0% |
Q1 2017 | $10,864,000 | +72.4% | 1,825,662 | +14.4% | 0.00% | – |
Q4 2016 | $6,302,000 | -61.4% | 1,595,289 | +2.5% | 0.00% | -100.0% |
Q3 2016 | $16,328,000 | -26.4% | 1,556,665 | +2.3% | 0.00% | 0.0% |
Q2 2016 | $22,187,000 | -22.5% | 1,521,695 | +2.3% | 0.00% | -50.0% |
Q1 2016 | $28,626,000 | -20.1% | 1,487,861 | +0.3% | 0.00% | 0.0% |
Q4 2015 | $35,833,000 | -88.0% | 1,483,161 | -84.4% | 0.00% | -81.8% |
Q3 2015 | $299,168,000 | +981.9% | 9,507,084 | +705.4% | 0.01% | +450.0% |
Q2 2015 | $27,651,000 | +22.2% | 1,180,376 | +17.0% | 0.00% | 0.0% |
Q1 2015 | $22,634,000 | +40.4% | 1,009,063 | +5.6% | 0.00% | +100.0% |
Q4 2014 | $16,117,000 | – | 955,956 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |